analyzed Survival curves of overall survival (OS), cancer-specific survival (CSS), and relapse-free survival (RFS) by (ELISA) measuring preoperative serum levels of CCL3, CCL4, and CCL5 in 114 patients with CRC (TNM stage 0, I, II:67 TNM stage III, IV:47). This evidence concerns the gene CCL3 and colorectal carcinoma.